Public Health screening in the pharmacy: a focus on Chlamydia

Louise Deeks, Gabrielle Cooper, Mark Naunton

Research output: Contribution to journalArticle

Abstract

Screening is use to identify signs of disease in individuals who lack symptoms. Unless everyone in a population is screened, screening is selective or targetted and is linked to risk assessment where only those at higher risk of disease are tested.
Original languageEnglish
Pages (from-to)210-212
Number of pages3
JournalAustralian Pharmacist
VolumeMarch
Publication statusPublished - 2012

Fingerprint

Chlamydia
Public Health
Population

Cite this

Deeks, Louise ; Cooper, Gabrielle ; Naunton, Mark. / Public Health screening in the pharmacy: a focus on Chlamydia. In: Australian Pharmacist. 2012 ; Vol. March. pp. 210-212.
@article{6a82fc93073b45a0a83f3365f30cc692,
title = "Public Health screening in the pharmacy: a focus on Chlamydia",
abstract = "Screening is use to identify signs of disease in individuals who lack symptoms. Unless everyone in a population is screened, screening is selective or targetted and is linked to risk assessment where only those at higher risk of disease are tested.",
keywords = "Sreening, disease, chlamydia, pharmacy, public health",
author = "Louise Deeks and Gabrielle Cooper and Mark Naunton",
year = "2012",
language = "English",
volume = "March",
pages = "210--212",
journal = "Australian Pharmacist",
issn = "0728-4632",

}

Public Health screening in the pharmacy: a focus on Chlamydia. / Deeks, Louise; Cooper, Gabrielle; Naunton, Mark.

In: Australian Pharmacist, Vol. March, 2012, p. 210-212.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Public Health screening in the pharmacy: a focus on Chlamydia

AU - Deeks, Louise

AU - Cooper, Gabrielle

AU - Naunton, Mark

PY - 2012

Y1 - 2012

N2 - Screening is use to identify signs of disease in individuals who lack symptoms. Unless everyone in a population is screened, screening is selective or targetted and is linked to risk assessment where only those at higher risk of disease are tested.

AB - Screening is use to identify signs of disease in individuals who lack symptoms. Unless everyone in a population is screened, screening is selective or targetted and is linked to risk assessment where only those at higher risk of disease are tested.

KW - Sreening

KW - disease

KW - chlamydia

KW - pharmacy

KW - public health

M3 - Article

VL - March

SP - 210

EP - 212

JO - Australian Pharmacist

JF - Australian Pharmacist

SN - 0728-4632

ER -